POLISCOPE
Back to feed
NewsWFLA News Channel 8October 28, 2026Hillsborough County

Heineken warns U.K. hospitality customers that GLP-1 medications could reduce beer sales and alter drinking habits

Photo: WFLA News Channel 8

Heineken advised U.K. hospitality customers earlier this month that the growing popularity of GLP-1 medications may reduce alcohol consumption and lead to smaller servings in pubs and bars. Research cited in the report indicates that GLP-1 users spend 30% less on alcohol at venues and 22% less at home, prompting differing responses from other brewers regarding strategy adjustments.

Read the full story at WFLA News Channel 8

Why It Matters

Changes in drinking habits driven by medications could alter revenues and product offerings across the hospitality and brewing sectors, with studies showing notable drops in consumer spending on alcohol.

Key Facts

  • Heineken presented a document to U.K. hospitality customers advising that GLP-1 medications could change drinking habits and result in fullness and fewer serves.
  • Research by Drinkaware and KAM found that GLP-1 users spent 30% less on alcohol when visiting pubs, bars, and restaurants.
  • Weekly spending on alcohol for home consumption among GLP-1 users fell by 22%, according to the report.
  • Heineken's research indicated consumers are increasingly choosing smaller servings, lower-alcohol beverages, and premium products.
  • Heineken advised hospitality customers to consider offering half-pints and low- and no-alcohol options.
  • Damm's managing director of UK business stated the company would not actively pursue a GLP-1-focused strategy due to legislative reasons and claims verification.
  • Other brewers, including Diageo and Carlsberg, also held differing opinions on Heineken's warning.

Who's Mentioned